Sophia Genetics SA [SOPH] vs Performant [PHLT] Detailed Stock Comparison
Sophia Genetics SA
NASDAQ
Loading...
Performant
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Sophia Genetics SA wins in 5 metrics, Performant wins in 12 metrics, with 0 ties. Performant appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Sophia Genetics SA | Performant | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -3.41 | -58.69 | Performant |
| Price-to-Book Ratio | 2.85 | 7.33 | Sophia Genetics SA |
| Debt-to-Equity Ratio | 83.21 | 11.04 | Performant |
| PEG Ratio | -0.08 | 0.34 | Sophia Genetics SA |
| EV/EBITDA | -2.85 | 325.46 | Sophia Genetics SA |
| Profit Margin (TTM) | -105.32% | -0.64% | Performant |
| Operating Margin (TTM) | -100.92% | 6.98% | Performant |
| EBITDA Margin (TTM) | N/A | 6.98% | N/A |
| Return on Equity | -74.09% | -1.12% | Performant |
| Return on Assets (TTM) | -23.46% | -0.03% | Performant |
| Free Cash Flow (TTM) | $-51.00M | $-832,000 | Performant |
| 1-Year Return | -13.60% | 107.90% | Performant |
| Price-to-Sales Ratio (TTM) | 3.14 | 4.39 | Sophia Genetics SA |
| Enterprise Value | $187.95M | $602.75M | Performant |
| EV/Revenue Ratio | 2.70 | 4.39 | Sophia Genetics SA |
| Gross Profit Margin (TTM) | 66.97% | N/A | N/A |
| Revenue per Share (TTM) | $1 | $2 | Performant |
| Earnings per Share (Diluted) | $-1.10 | $-0.01 | Performant |
| Beta (Stock Volatility) | 1.02 | 0.49 | Performant |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Sophia Genetics SA vs Performant Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Sophia Genetics SA | -4.99% | -6.36% | -5.26% | 6.23% | 4.18% | 1.57% |
| Performant | -0.39% | 0.00% | 0.13% | 154.33% | 179.49% | 151.82% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Sophia Genetics SA | -13.60% | 5.19% | -80.67% | -80.67% | -80.67% | -80.67% |
| Performant | 107.90% | 243.69% | 1,073.85% | 140.69% | -28.02% | -28.02% |
Performance & Financial Health Analysis: Sophia Genetics SA vs Performant
| Metric | SOPH | PHLT |
|---|---|---|
| Market Information | ||
| Market Cap | $218.96M | $602.75M |
| Market Cap Category | Micro cap | Small cap |
| 10 Day Avg. Volume | 44,660 | 1,069,059 |
| 90 Day Avg. Volume | 76,097 | 2,005,090 |
| Last Close | $3.24 | $7.63 |
| 52 Week Range | $2.58 - $4.92 | $2.17 - $7.74 |
| % from 52W High | -34.15% | -1.42% |
| All-Time High | $19.80 (Aug 30, 2021) | $14.09 (Mar 04, 2013) |
| % from All-Time High | -83.64% | -45.85% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.16% | 0.29% |
| Quarterly Earnings Growth | 0.16% | 0.29% |
| Financial Health | ||
| Profit Margin (TTM) | -1.05% | -0.01% |
| Operating Margin (TTM) | -1.01% | 0.07% |
| Return on Equity (TTM) | -0.74% | -0.01% |
| Debt to Equity (MRQ) | 83.21 | 11.04 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $1.14 | $1.04 |
| Cash per Share (MRQ) | $1.40 | $0.12 |
| Operating Cash Flow (TTM) | $-36,724,000 | $4.81M |
| Levered Free Cash Flow (TTM) | $-21,213,750 | $1.07M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Sophia Genetics SA vs Performant
| Metric | SOPH | PHLT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -3.41 | -58.69 |
| Forward P/E | -4.00 | 60.24 |
| PEG Ratio | -0.08 | 0.34 |
| Price to Sales (TTM) | 3.14 | 4.39 |
| Price to Book (MRQ) | 2.85 | 7.33 |
| Market Capitalization | ||
| Market Capitalization | $218.96M | $602.75M |
| Enterprise Value | $187.95M | $602.75M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.70 | 4.39 |
| Enterprise to EBITDA | -2.85 | 325.46 |
| Risk & Other Metrics | ||
| Beta | 1.02 | 0.49 |
| Book Value per Share (MRQ) | $1.14 | $1.04 |
Financial Statements Comparison: Sophia Genetics SA vs Performant
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SOPH | PHLT |
|---|---|---|
| Revenue/Sales | $18.32M | $33.27M |
| Cost of Goods Sold | $6.05M | N/A |
| Gross Profit | $12.27M | N/A |
| Research & Development | $8.49M | N/A |
| Operating Income (EBIT) | $-18.49M | $150,000 |
| EBITDA | $-15.70M | $1.85M |
| Pre-Tax Income | $-21.65M | $-41,000 |
| Income Tax | $762,000 | $40,000 |
| Net Income (Profit) | $-22.41M | $-81,000 |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SOPH | PHLT |
|---|---|---|
| Cash & Equivalents | $68.53M | $9.98M |
| Total Current Assets | $90.05M | $41.97M |
| Total Current Liabilities | $28.94M | $16.40M |
| Long-Term Debt | $27.84M | $8.72M |
| Total Shareholders Equity | $85.61M | $78.13M |
| Retained Earnings | $-457.66M | $-75.28M |
| Property, Plant & Equipment | $4.99M | $867,000 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SOPH | PHLT |
|---|---|---|
| Operating Cash Flow | $-11.17M | $898,000 |
| Capital Expenditures | $0 | $-1.45M |
| Free Cash Flow | $-12.24M | $1.45M |
| Debt Repayment | $-463,000 | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SOPH | PHLT |
|---|---|---|
| Shares Short | 40,888 | 3.90M |
| Short Ratio | 0.53 | 2.14 |
| Short % of Float | 0.00% | 0.09% |
| Average Daily Volume (10 Day) | 44,660 | 1,069,059 |
| Average Daily Volume (90 Day) | 76,097 | 2,005,090 |
| Shares Outstanding | 66.69M | 78.31M |
| Float Shares | 50.71M | 46.95M |
| % Held by Insiders | 0.06% | 0.08% |
| % Held by Institutions | 0.48% | 0.92% |
Dividend Analysis & Yield Comparison: Sophia Genetics SA vs Performant
| Metric | SOPH | PHLT |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |